Toulose, France Clinical Trials

A listing of Toulose, France clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 129 clinical trials
A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

This study is open to adults with a chronic inflammatory skin disease called hidradenitis suppurativa. The purpose of this study is to find out whether a medicine called spesolimab helps people with moderate to severe hidradenitis suppurativa. Participants are put into 2 groups by chance. One group takes spesolimab. The …

antibiotics
abscess
Hospital Santa Creu i Sant Pau
 (155.0 away) Contact site
  • 0 views
  • 01 Aug, 2021
  • +24 other locations
Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic Syndromes

Myelodysplastic syndromes (MDS) prevail in older age and are characterized by ineffective erythropoiesis and peripheral cytopenias. Supportive therapy is the main therapeutic option for most patients. Quality of Life (QoL) is mainly deteriorated by anemia and by the limitations associated with thrombocytopenia, neutropenia and transfusion dependence. The only available treatment …

myeloid leukemia
bone marrow procedure
lenalidomide
hysterectomy
stem cell transplantation
CHU de Haut-L v que
 (131.0 away) Contact site
  • 19 views
  • 23 Jan, 2021
  • +81 other locations
Study of Lademirsen (SAR339375) in Patients With Alport Syndrome

Primary Objectives: To assess the efficacy of lademirsen (SAR339375) in reducing the decline in renal function To assess the safety and tolerability of lademirsen (SAR339375) in subjects with Alport syndrome Secondary Objectives: To assess plasma pharmacokinetic (PK) parameters of the parent compound and its metabolites To assess the potential formation …

Investigational Site Number 7240001
 (154.0 away) Contact site
  • 485 views
  • 01 Aug, 2021
  • +51 other locations
Phase 2 Study of Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation

This is a Phase 2, open-label, multi-center study to evaluate the efficacy and the safety/tolerability of poziotinib in seven patient cohorts for up to 603 previously treated and treatment-nave NSCLC patients. Cohorts 3 and 4 were added with Amendment 1 and three additional cohorts were added with Amendment 2 (Cohorts …

stage iv non-small cell lung cancer
erbb2
EGFR
HER2
cancer chemotherapy
University Hospital Germans Trias i Pujol, Department of Medical Oncology
 (157.2 away) Contact site
  • 320 views
  • 13 May, 2021
  • +68 other locations
Efficacy and Safety of TD-1473 in Crohn's Disease

A Phase 2 study to evaluate the efficacy, safety and tolerability of TD-1473 in subjects with moderately-to-severely active Crohn's Disease with up to 48 weeks of treatment.

crohn's disease
anti-tnf therapy
immunomodulators
ulceration
corticosteroids
Theravance Biopharma Investigational Site
 (156.6 away) Contact site
  • 317 views
  • 28 Jan, 2021
  • +208 other locations
MALIBU Trial - Combination of Ibrutinib and Rituximab in Untreated Marginal Zone Lymphomas

Single-arm, phase II clinical trial of patients with Extranodal Marginal Zone Lymphoma (EMZL). It is planned to recruit 130 patients. Additional patients with Splenic Marginal Zone Lymphoma (SMZL), up to 30, and Nodal Marginal Zone Lymphoma (NMZL), up to 15, will be included in the trial in order to preliminary …

remission
gastric malt lymphoma
rituximab
lymphadenopathy
antiviral
IUCT Oncopole Toulouse
 (3.8 away) Contact site
  • 51 views
  • 16 Jun, 2021
  • +53 other locations
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)

This study will assess the antitumor activity, safety, tolerability, and pharmacokinetics (PK) of the Mesenchymal-epithelial Transition Factor (MET) inhibitor tepotinib combined with the 3rd generation EGFR inhibitor osimertinib in participants with advanced or metastatic non-small cell lung cancer (NSCLC).

stage iv non-small cell lung cancer
epidermal growth factor receptor
epidermal growth factor
growth factor
EGFR
CHU de Toulouse - H pital Larrey - Service de Pneumologie et Oncologie Pneumologique
 (0.0 away) Contact site
  • 84 views
  • 01 Aug, 2021
  • +174 other locations
A Study of Daratumumab Monotherapy in Previously Untreated Patients With Stage 3B Light Chain (AL) Amyloidosis

This is an open-label, multicenter, Phase 2 study in subjects with newly diagnosed stage 3B light chain (AL) amyloidosis.

Hopitaux Universitaires Henri-Mondor
 (360.2 away) Contact site
  • 2 views
  • 11 Feb, 2021
  • +4 other locations
A Study in Parkinson's Disease in Patients With Moderate to Severe Dyskinesia

The current study will explore the efficacy, safety and tolerability of 2 dose combinations of JM-010 to determine the optimal doses of each component to be studied in confirmatory clinical trials.

combinations
dyskinesia
parkinson's disease
levodopa
Contera Investigational site_ES
 (342.6 away) Contact site
  • 10 views
  • 30 May, 2021
  • +4 other locations
Investigating Efficacy and Safety of Once-weekly NNC0195-0092 (Somapacitan) Treatment Compared to Daily Growth Hormone Treatment (Norditropin FlexPro ) in Growth Hormone Treatment na ve Pre-pubertal Children With Growth Hormone Deficiency

This trial is conducted globally. The aim of the trial is to investigate efficacy and safety of once-weekly NNC0195-0092 (somapacitan) treatment compared to daily growth hormone treatment (Norditropin FlexPro) in growth hormone treatment nave pre-pubertal children with growth hormone deficiency. The trial consists of a 26 week main trial period, …

Novo Nordisk Investigational Site
 (2.0 away) Contact site
  • 38 views
  • 09 May, 2021
  • +56 other locations